Clinical Trial Update: Efficacy of Pramlintide on Prevention of Weight Gain Early Onset of Type 1 Diabetes [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating pramlintide to prevent weight gain in early onset Type 1 Diabetes was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• pramlintide (pramlintide)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Type 1 Diabetes | Phase 4 | Status: WITHDRAWN